{"id": "Medicine_tweet_13_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P <.01) and oral sex (from 25% to 80%; P <.01) were reported.\"><b>Finding:</b></span> Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status.", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 40s "}}
{"id": "Medicine_tweet_24_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  \"><b>Finding:</b></span> Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  ", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": [{"start": 431, "end": 444, "span": " ineffective.", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 1m 4s "}}
{"id": "Experience.html", "displayed_text": "Experience", "label_annotations": {"How satisfied do you feel about your experience participating in our study?": {"scale_4": "4"}, "Compared to other studies you've participated in, how do you rate the difficulty of this task?": {"scale_5": "5"}, "How confident are you that you performed well in the task?": {"scale_1": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 18s "}}
{"id": "test_question_testing_Somewhat uncertain", "displayed_text": "<b>Reported Finding:</b> New study suggests that sunscreen could prevent skin damage. This is a test question, please select Somewhat uncertain. Do not mark any words or phrases.", "label_annotations": {"how-certain-is-the-finding": {"Somewhat uncertain": "2"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 21s "}}
{"id": "Consent.html", "displayed_text": "Consent", "label_annotations": {"I have read and understood the instructions.": {"Yes": "I have read and understood the instructions.:::Yes"}, "I have read and understood the content warning.": {"Yes": "I have read and understood the content warning.:::Yes"}, "I want to participate in this research and continue with the study.": {"Yes": "I want to participate in this research and continue with the study.:::Yes"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 10s "}}
{"id": "Medicine_71_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Population prevalence of symptomatic radiographic foot OA Population prevalence estimates were almost identical in the baseline responder population and the total baseline eligible mailed population, hence the latter data are presented. The population prevalence of symptomatic radiographic foot OA in adults aged 50 years and over was 16.7% (95% CI 15.3% to 18.0%). The most commonly affected joint was the 1st MTPJ (7.8%; 95% CI 6.7% to 8.9%), followed by the 2nd CMJ (6.8%; 95% CI 5.7% to 7.8%), TNJ (5.8%; 95% CI 4.8% to 6.9%), NCJ (5.2%; 95% CI 4.0% to 6.4%) and 1st CMJ (3.9%; 95% CI 2.9% to 4.9%) (table 3) .\"><b>Finding:</b></span> The population prevalence of symptomatic radiographic foot OA in adults aged 50 years and over was 16.7% (95% CI 15.3% to 18.0%).", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 14s "}}
{"id": "Medicine_402_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: With recent support from the Food and Drug Administration on what could be the first-ever approved drug for the treatment of female sexual dysfunction, the researchers believe that HRV could be used as an index of drug-related changes in sexual function. \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton. \"It makes it easier to talk about something a little bit more private and get women the help that they need.\"\"><b>Finding:</b></span> \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton.", "label_annotations": {"how-certain-is-the-finding": {"Certain": "4"}}, "span_annotations": [{"start": 875, "end": 885, "span": "shows that", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 1m 7s "}}
{"id": "Medicine_tweet_13_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  \"><b>Finding:</b></span> Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  ", "label_annotations": {"how-certain-is-the-finding": {"Somewhat certain": "3"}}, "span_annotations": [{"start": 338, "end": 348, "span": "assoc w/ c", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 25s "}}
{"id": "Medicine_56_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).\"><b>Finding:</b></span> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": [{"start": 1344, "end": 1348, "span": "was ", "annotation": "Words indicating uncertainty"}, {"start": 1348, "end": 1352, "span": "not ", "annotation": "Words indicating uncertainty"}, {"start": 1352, "end": 1366, "span": "significantly ", "annotation": "Words indicating uncertainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 42s "}}
{"id": "Medicine_56_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.\"><b>Finding:</b></span> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).", "label_annotations": {"how-certain-is-the-finding": {"Certain": "4"}}, "span_annotations": [{"start": 857, "end": 868, "span": "was similar", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 51s "}}
{"id": "Certainty Examples.html", "displayed_text": "Certainty Examples", "label_annotations": {"I carefully went over the examples and the instructions.": {"Yes": "I carefully went over the examples and the instructions.:::Yes"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 3m 54s "}}
{"id": "Medicine_71_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: With 19 years of follow-up, Chingford is far and away the largest and longest longitudinal study of first MTP joint OA. Among the 557 symptomatic participants with foot x-rays, the prevalence of radiographic OA of the foot was 16.7%, or roughly one in six - underscoring that it's a common condition. The first MTP joint was the most commonly affected site, with a prevalence of 7.8%, followed by the second cuneometatarsal joint (CMJ) at 6.8%, the talonavicular joint (TNJ) at 5.2%, the navicular first cuneiform joint (NCJ) at 5.2%, and the first CMJ at 3.9%.\"><b>Finding:</b></span> Among the 557 symptomatic participants with foot x-rays, the prevalence of radiographic OA of the foot was 16.7%, or roughly one in six - underscoring that it's a common condition.", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 51s "}}
{"id": "Medicine_402_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p \\ .001) and overall sexual dysfunction (p \\ .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. Given these findings, it is reasonable to expect ANS activity (indexed by HRV) may be related to women's self-reported, real-life sexual arousal function outside of the laboratory.\"><b>Finding:</b></span> In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction.", "label_annotations": {"how-certain-is-the-finding": {"Certain": "4"}}, "span_annotations": [{"start": 694, "end": 707, "span": "In conclusion", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 18s "}}
{"id": "test_question_testing_Uncertain", "displayed_text": "<b>Reported Finding:</b> New study suggests that sunscreen could prevent skin damage. This is a test question, please select Uncertain. Do not mark any words or phrases.", "label_annotations": {"how-certain-is-the-finding": {"Somewhat certain": "3"}}, "span_annotations": [{"start": 87, "end": 92, "span": "could", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 30s "}}
{"id": "Medicine_tweet_24_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: Findings In this randomized clinical trial of 512 adults, the proportion achieving ureteral stone expulsion by 28 days was 50% with tamsulosin vs 47% with placebo, a nonsignificant difference. Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage. In the 11 cases for which this algorithm did not yield a clear result, the CT scans were individually reviewed and a consensus was reached.\"><b>Finding:</b></span> Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage.", "label_annotations": {"how-certain-is-the-finding": {"Uncertain": "1"}}, "span_annotations": [{"start": 809, "end": 817, "span": "does not", "annotation": "Words indicating uncertainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 1m 20s "}}
{"id": "Medicine_tweet_68_p", "displayed_text": "<span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: We found that maternal vitamin D supplementation timing, dose, and administration method did not affect cord blood vitamin D concentration. Late vitamin D supplementation (initiation at \u226520 weeks' gestation) improved birth weight, but early supplementation (initiation at <20 weeks' gestation) did not. Most importantly, we found that the lower dose of vitamin D supplementation (\u22642000 IU/d) reduced the risk of fetal or neonatal mortality and SGA, but the higher dose (>2000 IU/d) did not.\"><b>Finding:</b></span> Late vitamin D supplementation (initiation at \u226520 weeks' gestation) improved birth weight, but early supplementation (initiation at <20 weeks' gestation) did not.", "label_annotations": {"how-certain-is-the-finding": {"Certain": "4"}}, "span_annotations": [{"start": 740, "end": 749, "span": " improved", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 22s "}}
{"id": "Medicine_tweet_68_r", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Context: #Vitamin D supplementation during #pregnancy may reduce the risk for underweight babies and fetal or infant mortality. \"><b>Finding:</b></span> #Vitamin D supplementation during #pregnancy may reduce the risk for underweight babies and fetal or infant mortality. ", "label_annotations": {"how-certain-is-the-finding": {"Somewhat certain": "3"}}, "span_annotations": [{"start": 346, "end": 350, "span": "may ", "annotation": "Words indicating certainty"}], "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 20s "}}
